Proactive health management is taking centre stage as Bangkok Dusit Medical Services Public Company Limited (BDMS), a leading international private hospital network, introduces the ‘BDMS SPOT-MAS’ cancer screening package. This innovative test detects early-stage cancer cells through a single blood sample, under the concept ‘Early Detection, Better Outcomes – Comprehensive Screening for 10 Cancers.’ The initiative aims to improve treatment opportunities and disease control from the earliest stages.
Cancer often develops silently, showing no symptoms until it has advanced. Early detection, therefore, plays a vital role in improving survival rates and treatment effectiveness. The BDMS SPOT-MAS package is designed to screen and assess the risk of ten major cancer types – breast, lung, liver, oesophageal, colorectal, endometrial, pancreatic, ovarian, gastric, and head and neck cancers.
Cancer remains one of the world’s most pressing public-health challenges. According to the World Health Organization (WHO), approximately 19.9 million people were diagnosed with cancer globally in 2022, a number expected to climb to 35 million by 2050 due to an ageing population and lifestyle-related risk factors.
In Thailand, data from the National Cancer Institute show around 140,000 new cancer cases annually, with approximately 83,000 deaths – averaging more than 227 fatalities per day. The leading causes of cancer-related deaths among Thais include liver and bile duct cancer, lung cancer, breast cancer, cervical cancer, and leukaemia, highlighting the urgent need for preventive measures.
The BDMS SPOT-MAS package targets the most prevalent and high-risk cancers using advanced genetic biomarker testing technology, enabling early identification of cancer risk and cellular abnormalities under the supervision of specialised physicians. Screening items may vary by hospital. The package is recommended for individuals aged 40 and above, or those at high risk, serving as a crucial first step in prevention, ongoing monitoring, and personalised treatment planning based on medical advice.
BDMS continues to advance medical innovation for modern healthcare, ensuring greater access to effective screening and early intervention. The BDMS SPOT-MAS package is available from 1 October to 15 November 2025 at BDMS-affiliated hospitals, including Bangkok Hospital, Samitivej Hospital, BNH Hospital, Phyathai Hospital, Paolo Hospital, and BDMS Wellness Clinic.